Overview

A Methodological Study To Evaluate The Effects of Single Oral Doses Of Pioglitazone 45 mg And Rosiglitazone 8 mg On Sodium Balance In Healthy Male Volunteers

Status:
Completed

Trial end date:
2010-03-01

Target enrollment:

Participant gender:

Summary

A single centre, open, randomized, placebo controlled, 3 period cross-over study to evaluate the effects of single oral doses of pioglitazone 45mg, rosiglitazone 8mg and placebo on urinary sodium excretion in 12 healthy male volunteers

Phase:

Phase 1

Details

Lead Sponsor:

Solvay Pharmaceuticals

Treatments:

Pioglitazone
Rosiglitazone